Abstract
Collagen crosslinking (CXL) has been proposed as a treatment for infectious keratitis. Given the insurgence of antibiotic-resistant microorganisms and frequent toxicity of topical medications, CXL may be a potential treatment for corneal infections. However, corneal infection is itself a possible complication of this treatment. We describe a case of severe corneal thinning and melting in a woman who had a CXL procedure as a treatment for herpetic keratitis.
Copyright © 2013 ASCRS and ESCRS. Published by Elsevier Inc. All rights reserved.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acyclovir / therapeutic use
-
Antiviral Agents / therapeutic use*
-
Collagen / metabolism*
-
Combined Modality Therapy
-
Cornea / pathology
-
Corneal Perforation / etiology*
-
Corneal Perforation / pathology
-
Corneal Perforation / surgery
-
Corneal Stroma / metabolism
-
Cross-Linking Reagents / therapeutic use*
-
Female
-
Humans
-
Keratitis, Herpetic / drug therapy
-
Keratitis, Herpetic / surgery
-
Keratitis, Herpetic / therapy*
-
Keratoplasty, Penetrating
-
Middle Aged
-
Photochemotherapy*
-
Photosensitizing Agents / therapeutic use
-
Postoperative Complications*
-
Riboflavin / therapeutic use
-
Ultraviolet Rays
Substances
-
Antiviral Agents
-
Cross-Linking Reagents
-
Photosensitizing Agents
-
Collagen
-
Riboflavin
-
Acyclovir